Monitored Therapeutics, Inc. — Form D
Monitored Therapeutics, Inc. of DUBLIN, OH, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-01. The offering totals $5.0M, of which $4.1M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-04-01
- Form: D
- Accession: 0001794617-20-000002
- Industry: Other Health Care
- Exemptions: 04
- Total offering: $5.0M
- Amount sold: $4.1M
- Remaining: $862K
- Investors: 17
- Date of first sale: 2020-03-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-364154
Issuer
- Name: Monitored Therapeutics, Inc.
- CIK: 0001721865
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5995 Shier Rings Road, DUBLIN, OH, 43016
- Phone: 6147613555
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Steve Han | Director | Huntington Beach, CA |
| Alex Stenzler | Director | Long Beach, CA |
| Barry Sugarman | Director | Pacific Palisades, CA |
| James Kamnikar | Executive Officer | Powell, OH |
| MARK SHARY | Director | Indianapolis, IN |
| Michael Taylor | Director | Westlake Village, CA |
| Michael Taylor | Executive Officer | Westlake Village, CA |
| William Ross | Director | Grand Bay, AL |
| Kamnikar Jim | Executive Officer | Dublin, OH |
| Alex Charles Stenzler | Director | Lond Beach, CA |
| Michael Stock Taylor | Director | Dublin, OH |
| William Stock Ross | Director | Las Vegas, NV |
| William Charles Zimlich | Director | Dublin, OH |
| William Charles Zimlich | Executive Officer | Dublin, OH |
Other filings by this issuer (2)
More